Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Fulvio Spirito"'
Autor:
Giuseppe Losurdo, R. Lovero, Rosa Federica La Fortezza, M. Gentile, Angelo Andriulli, Fulvio Spirito, Alfredo Di Leo
Publikováno v:
European journal of clinical investigationREFERENCES.
Background Acute obstructive colorectal cancer requires prompt decompression commonly by emergency surgery (ES). However, self-expanding metal stents (SEMS) have been increasingly used as a bridge-to-surgery (BTS) strategy. Materials and methods In a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a6e1611faf634bafc3470f2ed742110
https://pubmed.ncbi.nlm.nih.gov/32323307
https://pubmed.ncbi.nlm.nih.gov/32323307
Autor:
A. Di Leo, Giuseppe Losurdo, R. Lovero, R.F. La Fortezza, M. Principi, Fulvio Spirito, M. Gentile, Angelo Andriulli
Publikováno v:
Digestive and Liver Disease. 52:S172
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::161e2cef9ffc474f6e8328d1cb9fc763
https://doi.org/10.1016/s1590-8658(20)30875-6
https://doi.org/10.1016/s1590-8658(20)30875-6
Autor:
Angelo Andriulli, Grazia Anna Niro, Grazia Napolitano, Rosario Forlano, Fulvio Spirito, Alberto Pilotto, Maria Rosa Valvano, Silvano Loperfido
Publikováno v:
The American Journal of Gastroenterology. 102:1781-1788
OBJECTIVES: To provide health-care providers, patients, and physicians with an exhaustive assessment of prospective studies on rates of complications and fatalities associated with endoscopic retrograde cholangiopancreatography (ERCP). METHODS: We se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d25421c1d9c539502f70319aeba843ac
https://doi.org/10.1111/j.1572-0241.2007.01279.x
https://doi.org/10.1111/j.1572-0241.2007.01279.x
Autor:
Fulvio Spirito, Angelo Andriulli, D. Bacca, Mario R. Romano, Gaetano Scotto, Marcello Persico, Fernando Sogari, G.L. Ricci, Nicola Minerva, Mauro Annese, Alessandra Mangia, Francesco Vinelli, Rosanna Santoro, Franco Zechini, Vito Carretta
Publikováno v:
New England Journal of Medicine. 352:2609-2617
background We hypothesized that in patients with hepatitis C virus (HCV) genotype 2 or 3 in whom HCV RNA is not detectable after 4 weeks of therapy, 12 weeks of treatment is as effective as 24 weeks. methods A total of 283 patients were randomly assi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c43046b0ef065d08e8c77719a00e63
https://doi.org/10.1056/nejmoa042608
https://doi.org/10.1056/nejmoa042608
Autor:
Giovambattista Forte, Angelo Andriulli, Vittorio Terruzzi, Virginia Festa, Maria Rita Magnolia, Francesco Perri, Fabio Monica, Pietro Leo, Enrico Ciliberto, Angelo Belmonte, Michele Silla, Fulvio Spirito, L. Solmi, Giorgio Marenco, Silvano Loperfido, Antonio Di Sabatino
Publikováno v:
Clinical Gastroenterology and Hepatology. 2:713-718
Background & Aims: It still is debated whether post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis can be prevented by administering either somatostatin or gabexate mesylate. The aim of the study is to assess the efficacy of a 6.5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4dd78750121fa173fa4e96026d7bcff
https://doi.org/10.1016/s1542-3565(04)00295-2
https://doi.org/10.1016/s1542-3565(04)00295-2
Autor:
Mauro Annese, Vito Carretta, Alessandra Mangia, M. Cela, Fulvio Spirito, Marisa Piattelli, Nicola Minerva, Gioacchino Leandro, Rosanna Santoro, Angelo Andriulli, D. Bacca, Francesco Ventrella
Publikováno v:
Journal of Hepatology. 37:109-116
The aim of the present, open-labelled, controlled study was to determine whether 5 MU of interferon (IFN) alpha 2b combined with a standard dose of ribavirin might increase the rate of viral clearance in all patients with chronic HCV hepatitis or at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::338ac03ee52d3f023260fd28a8b002e9
https://doi.org/10.1016/s0168-8278(02)00140-x
https://doi.org/10.1016/s0168-8278(02)00140-x
Autor:
Giorgio Verme, Franco Macor, A. Solinas, Mario Rizzetto, Angelo Andriulli, Claudia Spezia, Carlo Donada, Vittorio Gallo, Valter Donadon, Alessandra Mangia, Giorgio Maria Saracco, E. Borghesio, Livio Chiandussi, Fulvio Spirito, Pietro Mesina
Publikováno v:
Journal of Hepatology. 27:56-62
Background/Aims: To examine the effect of prolonged treatment with different doses of interferon α-2b on the relapse rate in patients with chronic hepatitis C. Methods: One hundred and seventy-one patients with non-cirrhotic chronic hepatitis C were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffea0f16cf76785a5cf318aa962d6ec9
https://doi.org/10.1016/s0168-8278(97)80280-2
https://doi.org/10.1016/s0168-8278(97)80280-2
Autor:
Francesco Perri, Antonio Merla, M. Gentile, Daniela Scimeca, Angelo Andriulli, Fulvio Spirito, Fulvia Terracciano
Publikováno v:
Endoscopy. 43
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa878b01cd0be19416a146cef1267ece
https://pubmed.ncbi.nlm.nih.gov/22275032
https://pubmed.ncbi.nlm.nih.gov/22275032
Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial
Autor:
Giuseppe Cristofaro, Giuseppe Montalto, D. Bacca, Francesco Vinelli, Raffaele Cozzolongo, G.L. Ricci, Angelo Andriulli, Leonardo Mottola, Mario R. Romano, Nicola Minerva, Fulvio Spirito, Gaetano Scotto, Vito Carretta, Alessandra Mangia
It was hypothesized that in hepatitis C virus (HCV) genotype 1 patients, variable treatment duration individualized by first undetectable HCV RNA is as effective as standard 48-week treatment. Patients (n_696) received peginterferon alfa-2a, 180 mg/w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9c318ebec2b6d1d50877a8b937ff990
http://hdl.handle.net/11573/87790
http://hdl.handle.net/11573/87790
Autor:
M. Piattelli, Giovanni De Maio, Valerio Pazienza, Alessandra Mangia, Fulvio Spirito, Angelo Andriulli, Davide Festi, D. Bacca, M. Cela, G.L. Ricci, Marcello Persico, Nicola Minerva, Vincenzo Guadagnino, Mauro Annese, Vito Carretta, D. Conte
We determined whether triple therapy comprising amantadine (AMA), ribavirin (RBV) and either peginterferon (PEG-IFN) alpha-2a or conventional IFN alpha-2a would improve sustained virological response (SVR) rates over dual therapy with IFN alpha-2a an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e60c68e0835d5cf96e8e9e179884f8f2
http://hdl.handle.net/11386/3138191
http://hdl.handle.net/11386/3138191